Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells
Publication date:
2014
Editorial:
Hindawi Publishing Corporation
Publisher version:
Citación:
BioMed Research International, 2014 (2014); doi:10.1155/2014/265840
DOI:
Patrocinado por:
This work was supported by the Spanish grants of Fondo de Investigaciones Sanitarias (Instituto Carlos III) PS09/00420 and PI12/01280 and by the Celgene Corporation.
Collections
- Artículos [37321]
- Biología Funcional [791]
- Investigaciones y Documentos OpenAIRE [8282]
Files in this item
